Previous literature suggests that LAPTM4B aids cancer cells towards survival advantage by promoting resistance to hypoxic microenvironment, nutrient deprivation and genotoxic stress contemplated by chemotherapy (Dielschneider, Henson & Gibson, 2017). Here, LAPTM4B is linked to cancer.